Probi´s Annual General Meeting 2017

On Probi´s Annual General Meeting on 4 May 2017 in Lund, the following was resolved:

  • The Annual General Meeting approved the Annual Report and the Boards proposal for a dividend for the financial year 2016 corresponding to 1.00 SEK per share.The record date was set for 8 May 2017.
  • The Annual General Meeting discharged the Board members and the CEO from liability for the financial year 2016.
  • The Annual General Meeting resolved that the Board shall consist of six members without any deputies. The meeting re-elected the members Jan Nilsson, Jonny Olsson and Jean-Yves Parisot, and resolved on new election Anna Malm Bernsten, Scott Bush and Chalotte Hansson. Jean-Yves Parisot was re-elected as Chairman of the Board.
  • The Board fee was determined to a total of SEK 1,400,000, whereof SEK 400,000 to the Chairman and SEK 200,000 to each of the other members. In addition, fee for committee work was determined to SEK 70,000 to the Chairman of the Audit Committee and SEK 40,000 to the other members, and SEK 30,000 to Chairman of the Remuneration Committee and SEK 20,000 to the other members.
  • The Annual General Meeting re-elected the registered public accounting firm Deloitte AB, which had informed that Maria Ekelund should be the auditor in charge.
  • The Board´s proposal regarding guidelines for renumeration of senior executives was approved.
  • The Board was authorized, in accordance with its proposal, for the period until the next AGM and, on one or several occasions, to resolve on repurchase and transfers of own shares.
  • The Board was authorized, in accordance with its proposal, for the period until the next AGM and, on one or several occasions, to resolve on the issue of a maximum of 1,164,412 shares.
  • The Annual General Meeting appointed a nomination committee ahead of the Annual General Meeting 2018 consisting of Heinz-Jürgen Bertram (Symrise), Jannis Kitsakis (Fourth Swedish National Pension Fund), Marianne Flink (Swedbank Robur funds) and Bengt Jeppsson (Professor, Surgical Faculty, Lund University, representing the minor shareholders).

The CEO´s presentation will be available on

Peter Nählstedt, CEO, Probi, tel +46 46 286 89 23, e-mail:

Probi AB is a Swedish publicly traded bioengineering company. The vision of Probi is to help people live healthier lives by delivering effective and well-documented probiotics, with proven health benefits based on scientific research. Founded by scientists in Sweden in 1991, Probi is a multinational company with four centers of excellence, active in more than 40 markets around the world and holding over 400 patents worldwide. In 2016, Probi had net sales of MSEK 444. The Probi share is listed on Nasdaq Stockholm, Mid Cap. Probi has about 5,000 shareholders. Read more at


About Us

Probi AB is a Swedish publicly traded biotechnology company that develops effective and well-documented probiotics. Through its research, Probi has created a strong product portfolio in the gastrointestinal health and immune system areas. The products are available to consumers in more than 40 countries worldwide. The customers are leading food, health-product and pharmaceutical companies in the Functional Food and Consumer Healthcare segments. The Probi share is listed on NASDAQ OMX Stockholm, Mid-cap. Read more on



Documents & Links